HCPLive

Bone Loss Drugs Increase Stroke Risk in Patients with Cancer

Older patients with cancer taking bisphosphonates for bone metastases are at modestly increased risk for atrial fibrillation and stroke. According to a study published online in the Journal of Clinical Oncology, the absolute risk for these patients within 6 years of starting bisphosphonate treatment was approximately 8% for all supraventricular tachycardia events and 4% for stroke.

Article courtesy of http://www.onclive.com
 

Most Popular

Recommended Reading

GLP-1 receptor antagonists have been associated with thyroid cancer in rodents, and in fact carry a boxed warning about the potential for cancer in humans. This leads many clinicians to ask if they should be concerned about using these drugs in patients who have or develop specific types of thyroid cancer
Dementia is linked to comorbid diabetes and psychiatric conditions like depression, according to research from University College London.
Seizures and other neurological problems traced to pork tapeworms are a new health threat for the US, the CDC reports.
A recent study examined the cost of biologic and non-biologic DMARDs under Medicare Part D and stand-alone coverage plans.
$vAR$